Henry Schein Inc. will participate in September's
investor conferences, and reported a solid performance in its Q4 2023 and Q1-Q2 2024 earnings amidst challenges, despite a
guidance slash due to mostly unknown factors. The
Q2 earnings surpassed expectations but the company faces
mixed opinions from market participants. Various investors are gaining positions in the firm including
SG Americas Securities LLC and
Sequoia Financial Advisors LLC, while
Swedbank AB and
QRG Capital Management Inc. sold their shares. Their
Back to School program continues to empower students globally. However, shares fell on the guidance cut, and price targets were lowered by both
JP Morgan and
UBS Group. Henry Schein acquired
TriMed bolstering its position in the orthopedic space and partnered with
Viome to improve access to oral health programs. Despite perceived underperformance in acquisition strategy, the company shows strong long-term momentum.
Henry Schein HSIC News Analytics from Tue, 05 Dec 2023 08:00:00 GMT to Fri, 16 Aug 2024 16:22:40 GMT -
Rating -1
- Innovation 2
- Information 6
- Rumor -2
